News
MKGAF
161.75
-0.92%
-1.50
Key deals this week: Visa, London Stock Exchange, Tradeweb Markets, Salesforce, and more
Seeking Alpha · 1d ago
Silence Therapeutics: Downgrade To Hold On Merck KGaA Acquisition And PV siRNA
Seeking Alpha · 6d ago
Why Is Silence Therapeutics Stock Skyrocketing Monday?
Benzinga · 6d ago
Merck KGaA to buy Silence Therapeutics in all-cash deal
Seeking Alpha · 10/19 12:20
Weekly Report: what happened at MKGAF last week (1012-1016)?
Weekly Report · 10/19 09:28
Weekly Report: what happened at MKGAF last week (1005-1009)?
Weekly Report · 10/12 09:30
Weekly Report: what happened at MKGAF last week (0928-1002)?
Weekly Report · 10/05 09:30
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
Seeking Alpha · 10/02 11:32
Weekly Report: what happened at MKGAF last week (0921-0925)?
Weekly Report · 09/28 09:28
Is Bio-Techne Stock Outperforming the Nasdaq?
Barchart · 09/24 03:47
Weekly Report: what happened at MKGAF last week (0914-0918)?
Weekly Report · 09/21 09:28
Weekly Report: what happened at MKGAF last week (0907-0911)?
Weekly Report · 09/14 09:30
Weekly Report: what happened at MKGAF last week (0831-0904)?
Weekly Report · 09/07 09:27
Weekly Report: what happened at MKGAF last week (0824-0828)?
Weekly Report · 08/31 09:30
Weekly Report: what happened at MKGAF last week (0817-0821)?
Weekly Report · 08/24 09:30
First Eagle Overseas Equity ETF Q2 2026 Portfolio Review
Seeking Alpha · 08/23 16:11
Werewolf Therapeutics Takes Aim At Untapped Pain Market With Ambros Deal
Benzinga · 08/21 13:33
Ariel International Fund Q2 2026 Portfolio Update
Seeking Alpha · 08/20 09:10
Is Wall Street Bullish or Bearish on Bio-Techne Stock?
Barchart · 08/18 04:50
Weekly Report: what happened at MKGAF last week (0810-0814)?
Weekly Report · 08/17 09:31
More
Webull provides a variety of real-time MKGAF stock news. You can receive the latest news about Merck through multiple platforms. This information may help you make smarter investment decisions.
About MKGAF
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business segment is operating in the therapeutic areas of oncology, neurology & immunology and fertility as well as cardiovascular, metabolic and endocrinological disorders. The Life Sciences segment is operating with its three business units such as, Science & Lab Solutions, Process Solutions and Life Science Services. It is also a supplier of products, tools and services for research laboratories, pharmaceutical and biopharmaceutical production as well as industrial and testing laboratories. The Electronics business segment consists of the Semiconductor Solutions, Display Solutions and Surface Solutions business units. Its Semiconductor Solutions business unit consists of the thin films, formulations, specialty gases, and delivery systems & services business fields.